Fundraising FoxDementia Discovery Fund — 2023 Investments
7 investments dated 2023 · listed companies and verified rows first · show all
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Founder, QurAlis; Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Founder, Chief Executive Officer)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsALS Investment FundDolby Family VenturesDroia VenturesInkefMC Healthcare VenturesMission Biocapital+8 more
Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.
BiotechDigital HealthHealthtechMedical DevicesSacramento, US
Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in
BoardOlga Danilchanka(Director)inLaia Crespo-Martin(Director)
Co-investorsMRL Ventures FundSanofi VenturesSV Health InvestorsAngelini VenturesApollo Health VenturesDolby Family Ventures+2 more
Violet Labs builds software tools for engineers designing and building physical products across industries including aerospace, defense, robotics, and energy.
Data & InfrastructureDeveloper ToolsEnterprise SoftwareHardwareSan Francisco, US
Lucy Hoag(CEO)in
Co-investorsFelicis VenturesMaC Venture CapitalMairs & Power VCV1 VCHopelabNorthwell Holdings+4 more
Violet provides free, personalised support for Australian families navigating end-of-life care, combining human connection and technology to offer practical guidance, emotional support, and tools for important conversations.
Digital HealthFintechHealthtechImpact & Social GoodMental HealthHaymarket, AU
BoardKate Carnell(Chairperson)
Co-investorsTechstarsHopelabNorthwell HoldingsOno Venture Investment, Inc.SemperVirens Venture CapitalThe Venture Collective+1 more
Violet provides healthcare organizations with data analytics and tools to measure and improve their ability to deliver person-centered care that considers patients' individual preferences, identities, and experiences.
Data & InfrastructureDigital HealthHealthtechNew York City, US
Gaurang Choksi(CEO and Founder)inScott Zaloom(Head of Operations)inDr. Kay Nikiforova(Head of Clinical & Research)inEliot Kristan(Head of Engineering)in
Co-investorsGaingelsHead & Heart CapitalSeae VenturesSemperVirens Venture CapitalThe Venture CollectiveW Health Ventures Gp Llc+4 more
__Twitter.png)
Violet provides a unified API for commerce infrastructure that simplifies checkout, catalog management, and order processing for platforms and marketplaces serving multiple merchants.
B2B MarketplacesE-commerceSaaSSeattle, US
Brandon Schulz(Founder)inRhen Zabel(Executive Officer, Director, Promoter)Adam Dreiblatt(Director)
Co-investorsAlumni VenturesSeaChangeHopelabNorthwell HoldingsOno Venture Investment, Inc.Red Sea Ventures+4 more
Violet is a therapeutics company developing small molecule treatments for central nervous system diseases, using its proprietary C-to-C Engine platform to identify disease-relevant cell-to-cell interactions.
BiotechDeep TechCambridge, US
William E Yelle(Executive Officer, Director)Atsushi Usami(Director)Meredith Fisher(Executive Officer, Director)Jonathan Behr(Director)
Co-investorsDementia DiscoveryLifespan Vision VenturesOno Venture Investment, Inc.SV Health InvestorsUTEC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.